Tesser, John <br/><br/>
Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age.  [electronic resource] 

 -  Arthritis research & therapy  08 2019 
 - 190 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-019-1968-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--diagnosis<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Treatment Outcome